Mergers & Acquisitions ·
FTC issues Second Request for proposed merger with MiMedx
SMTISanara MedTech Inc.
The Federal Trade Commission issued a Second Request for additional information regarding the proposed merger between Sanara MedTech Inc. and MiMedx Group, Inc. This action extends the Hart-Scott-Rodino waiting period until 30 days after substantial compliance is achieved. The transaction remains subject to regulatory approval and other closing conditions. Sanara MedTech Inc. operates in the medical technology sector, specializing in regenerative medicine products for surgical procedures.